Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

Ultragenyx wins first gene therapy FDA approval for Genglycos (DTX401) targeting glycogen storage disease type Ia via Ph3
Gene therapy, metabolic, AAV vector, glycogen storage disease, rare disease - Read more

Regeneron wins FDA approval for Pasatru (garetosmab) targeting Activin A in fibrodysplasia ossificans progressiva based on Ph3 data
Antibody, rare bone disease, monoclonal antibody, fibrodysplasia ossificans progressiva, Activin A, heterotopic ossification - Read more

Eli Lilly's once-weekly insulin Onswik receives NICE recommendation for NHS coverage in UK
Injectable insulin, type 2 diabetes, regulatory, coverage - Read more

Vitestro's Aletta becomes first FDA-approved robotic blood draw device, addressing phlebotomist shortage
Robotic medical device, phlebotomy, regulatory, operational, investment - Read more

NICE backs Axunio UK's Axhidrox (glycopyrronium bromide) for severe primary axillary hyperhidrosis following Ph3 success
Small molecule, dermatological, anticholinergic, hyperhidrosis, glycopyrronium bromide - Read more

Ready to supercharge your marketing AND sales workflows into biopharma?

You won’t want to miss this webinar, where Kimo (Hapatune) and Anis (Science 2 Sales) get into the nitty-gritty of both:

• Audience segmentation (how tailored marketing content can more effectively engage a focused bioprocess customer segment) and
• Cold calling (the technical underpinning and strategies + mindset to win at it)

Join us August 26th - register for free here!

Eli Lilly, Amplitude Therapeutics collaborate on taRNA vaccine platform targeting infectious diseases
Research collaboration, infectious disease, vaccine, RNA platform, drug discovery - Read more

Chai Discovery, Bristol Myers Squibb collaborate on AI-powered therapeutic antibody discovery
Research collaboration, AI/ML, antibody, drug discovery - Read more

AlzeCure Pharma, Eli Lilly complete Alzstatin licensing deal, $10M upfront, $1B+ milestones
Licensing deal, neurological, small molecule, milestone payments, royalties - Read more

Akiram Therapeutics, ITM sign Lu-177 supply agreement to advance AKIR001 for solid tumors
Manufacturing agreement, oncology, radiopharmaceuticals, antibody, clinical trials - Read more

Onco-Innovations Limited, Ifowonco Informatics sign LOI for exclusive worldwide licence to LAG-3 small-molecule inhibitor program
Licensing deal, oncology, small molecule, immune checkpoint, co-development - Read more

Simcere Pharmaceutical Group, Ruiyang Biopharmaceutical partner to commercialize RSV monoclonal antibody kuleveibaimab in Greater China
Commercialization, infectious disease, antibody, licensing deal - Read more

Network Bio launches with $50M and NVIDIA partnership to build cross-disease AI medical intelligence platform
AI/machine learning, multiple disease areas, strategic, major transaction - Read more

Kynexis raises €97M ($113M) Series A, advancing cognitive impairment schizophrenia drug to registrational development
Neurological, small molecule, cognitive disorders, clinical-stage, schizophrenia - Read more

Pixelgen Technologies closes $15.5M oversubscribed Series B to accelerate global commercialization
Biomarker discovery, platform technology, proteomics, cancer, autoimmune - Read more

Amylyx Pharmaceuticals plans $500M share sale to fund avexitide PBH treatment launch preparations
Rare disease, small molecule, metabolic disease, clinical-stage - Read more

KaliVir Immunotherapeutics closes $14M Series A extension, advancing oncolytic immunotherapy clinical trial
Oncology, oncolytic immunotherapy, clinical-stage, solid tumors, viral platform - Read more

Greenstone Biosciences receives undisclosed Breakthrough T1D grant for islet cell platform development
AI-driven, iPSC platform, type 1 diabetes, drug discovery, organoids - Read more

Do you offer a biotech/pharma-focused product or service?

Or looking to get investor/analyst interest on your budding start-up?

Considering sponsoring TLDR Biotech to get in-front of an engaged audience of biotech & pharma-focused professionals.

Just reply to this email* or message me on LinkedIn to learn more.

*If you’re reading this on the web version, email [email protected]

Amgen terminates TScan Therapeutics Crohn's disease collaboration, walking away from $530M deal
Licensing deal, autoimmune, drug discovery, milestone payments, royalties - Read more

B. Braun Medical recalls IV solution in US and Canada over particulate contamination concerns
IV solution, hospital operations, product safety, operational - Read more

France recalls Amgen's Tavneos after 20 deaths reported in Japan, EU revokes marketing authorisation
Small molecule, rare disease, safety, regulatory - Read more

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

If you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

And lastly - connect with me on LinkedIn!

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here